CD274 and gastric carcinoma: In the present study, we propose that the extrinsic mechanism in tumoral PD-L1 expression may act more often in EBV-positive and MSI-high gastric carcinomas, indicating that PD-1/PD-L1 blockade immunotherapy may be advantageous in these patients.